Cell-penetrating peptideselectroporation and drug delivery

IET Systems Biology

Volumn 4, Issue 6, 2010, Pages 367-378

  Cahill, K ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL-PENETRATING PEPTIDE; ELECTROPORATION; MAMMALIAN CELLS; PLASMA MEMBRANES; TRANSCRIPTIONAL ACTIVATORS;

CHEMICAL ACTIVATION; CYTOLOGY; DRUG DELIVERY; MAMMALS; MOLECULAR BIOLOGY;

CELL MEMBRANES;

MAMMALIA;

CELL PENETRATING PEPTIDE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG STABILITY; ELECTROPORATION; HUMAN; LIPID BILAYER; MAMMAL; METHODOLOGY; NEOPLASM; PHYSIOLOGY; STATIC ELECTRICITY;

ANIMALS; CELL MEMBRANE; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ELECTROPORATION; HUMANS; LIPID BILAYERS; MAMMALS; MEMBRANE POTENTIALS; MODELS, BIOLOGICAL; NEOPLASMS; STATIC ELECTRICITY;

EID: 78149422223     PISSN: 17518849     EISSN: None     Source Type: Journal    
DOI: 10.1049/iet-syb.2010.0007     Document Type: Article

References (50)

1. ChorevM. GoodmanM.: 'A dozen years of retro-inverso peptidomimetics'Acc. Chem. Res.199326(5)p. 266-273
2. ManoharanM. KesavanV. RajeevK.G.: 'SiRNAs containing ribose substitutes to which lipophilic moieties may be attached'(US Patent Appl. Publ. US:2005107325)
3. LipinskiC. LombardoF. DominyB. FeeneyP.: 'Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings'Adv. Drug Deliv. Rev.199723p. 3-25
4. CahillK.E.: 'Simple model of the transduction of cell-penetrating peptides'IET Syst. Biol.20093(5)p. 300-306
5. CahillK.E.: 'Molecular electroporation and the transduction of oligoarginines'Phys. Biol.20107p. article id 016001 (14pp)1478-3967
6. HerceH.D. GarciaA.E. LittJ.: et al. 'Arginine-rich peptides destabilize the plasma membraneconsistent with a pore formation translocation mechanism of cell-penetrating peptides'Biophys. J.200997(7)p. 1917-19250006-3495
7. GreenM. LoewensteinP.M.: 'Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein'Cell198855(6)p. 1179-1188
8. FrankelA.D. PaboC.O.: 'Cellular uptake of the tat protein from human immunodeficiency virus'Cell198855(6)p. 1189-1193
9. LindbergM. JarvetJ. LangelÜ. GräslundA.: 'Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR'Biochemistry200140(10)p. 3141-3149
10. JiangT. OlsonE.S. NguyenQ.T. RoyM. JenningsP.A. TsienR.Y.: 'Tumor imaging by means of proteolytic activation of cell-penetrating peptides'Proc. Natl. Acad. Sci. USA2004101(51)p. 17867-178720027-8424
11. SnyderE. SaenzC. DenicourtC.,: 'Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides'Cancer Res.200565(23)p. 10646-10650
12. WillamC. MassonN. TianY.-M.: et al. 'Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis'Proc. Nat. Acad. Sci.200299(16)p. 10423-10428
13. ChenY.-N.P. SharmaS.K. RamseyT.M.: et al. 'Selective killing of transformed cells by cyclin/cyclindependent kinase 2 antagonists'Proc. Natl. Acad. Sci. USA199996(8)p. 4325-43290027-8424
14. MendozaN. FongS. MarstersJ. KoeppenH. SchwallR. WickramasingheD.: 'Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth'Cancer Res.200363(5)p. 1020-1024
15. HarbourJ.W. WorleyL. MaD. CohenM.: 'Transducible peptide therapy for uveal melanoma and retinoblastoma'Arch. Ophthalmol.2002120(10)p. 1341-1346
16. MaiJ.C. MiZ. KimS.-H. NgB. RobbinsP.D.: 'A proapoptotic peptide for the treatment of solid tumors'Cancer Res.200161(21)p. 7709-7712
17. DattaK. SundbergC. KarumanchiS.A. MukhopadhyayD.: 'The 104-123 amino acid sequence of the β-domain of von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion'Cancer Res.200161(5)p. 1768-1775
18. HosotaniR. MiyamotoY. FujimotoK.: et al. 'Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice'Clin. Cancer Res.20028(4)p. 1271-1276
19. ZhouJ. FanJ. HsiehJ.-T.: 'Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DOC-2/DAB2 delivered by a unique vehicle'Cancer Res.200666(18)p. 8954-8958
20. SnyderE. MeadeB. SaenzC. DowdyS.: 'Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide'PLoS Biol.20042(2)p. 0186-0193
21. HaaseH. DobbernackG. TünnemannG.: et al. 'Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats'FASEB J.200620(7)p. 865-873
22. TünnemannG. KarczewskiP. HaaseH. CardosoM.C. MoranoI.: 'Modulation of muscle contraction by a cell-permeable peptide'J. Mol. Med.200785(12)p. 1405-1412
23. ZieglerA. SeeligJ.: 'High affinity of the cell-penetrating peptide HIV-1 Tat-PTD for DNA'Biochemistry200746(27)p. 8138-8145
24. TünnemannG. MartinR.M. HauptS. PatschC. EdenhoferF. CardosoM.C.: 'Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells'FASEB J.200620(11)p. 1775-1784
25. WadiaJ.S. StanR.V. DowdyS.F.: 'Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis'Nat. Med.200410(3)p. 310-315
26. DuchardtF. Fotin-MleczekM. SchwarzH. FischerR. BrockR.: 'A comprehensive model for the cellular uptake of cationic cell-penetrating peptides'Traffic20078(7)p. 848-866
27. ProchiantzA.: 'Messenger proteins: homeoproteinsTAT and others'Curr. Opin. Cell Biol.200012(4)p. 400-406
28. DomG. Shaw-JacksonC. MatisC.: et al. 'Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophandependent translocation'Nucleic Acids Res.200331(2)p. 556-561
29. RothbardJ.B. JessopT.C. WenderP.A.: 'Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells'Adv. Drug Deliv. Rev.200557(4)p. 495-504
30. ZaroJ.L. ShenW.-C.: 'Evidence that membrane transduction of oligoarginine does not require vesicle formation'Exp. Cell Res.2005307p. 164-173
31. ZieglerA. NerviP. DürrenbergerM. SeeligJ.: 'The cationic cell-penetrating peptide CPPTAT derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: opticalbiophysicaland metabolic evidence'Biochemistry200544(1)p. 138-148
32. PatelL.N. ZaroJ.L. ShenW.-C.: 'Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives'Pharm. Res.200724(11)p. 1977-1992
33. FawellS. SeeryJ. DaikhY.: et al. 'Tatmediated delivery of heterologous proteins into cells'Proc. Natl. Acad. Sci. USA199491p. 6640027-8424
34. NagaharaH. Vocero-AkbaniA. SnyderE.: et al. 'Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1'Nat. Med.19984p. 1449
35. BulteJ.W.: 'Intracellular endosomal magnetic labeling of cells'Meth. Mol. Med.2006124p. 419
36. GardenO. ReynoldsP. YatesJ.: et al. 'A rapid method for labelling CD4+ T cells with ultrasmall paramagnetic iron oxide nanoparticles for magnetic resonance imaging that preserves proliferativeregulatory and migratory behaviour in vitro'J. Immunol. Meth.2006314p. 123-133
37. TünnemannG. Ter-AvetisyanG. MartinR.M. Martin StöcklM. HerrmannA. CardosoM.C.: 'Live-cell analysis of cell penetration ability and toxicity of oligo-arginines'J. Pept. Sci.200814(4)p. 469-4761075-2617
38. BeversE. ComfuriusP. DekkersD. ZwaalR.: 'Lipid translocation across the plasma membrane of mammalian cells'Biochim. Biophys. Acta19991439(3)p. 317-330
39. AlbertsB. JohnsonA. LewisJ. RaffM. RobertsK. WalterP.: 'Molecular biology of the cell'4th(Garland ScienceNew York 2002)p. 587-593
40. TyagiM. RusnatiM. PrestaM. GiaccaM.: 'Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans'J. Biol. Chem.2001276(5)p. 3254-3261
41. DaiJ. Ting-BeallH.P. SheetzM.P.: 'The secretion-coupled endocytosis correlates with membrane tension changes in RBL 2H3 cells'J. Gen. Physiol.1997110(1)p. 1-10
42. AbidorI.G. ArakelyanV.B. ChernomordikL.V. ChizmadzhevY.A. PastushenkoV.F. TarasevichM.R.: 'Electric breakdown of bilayer lipid membranes I. The main experimental facts and their qualitative discussion'Bioelectrochem. Bioenerg.19796p. 37-52
43. ChernomordikL.V. SukharevS.I. PopovS.V.: et al. 'The electrical breakdown of cell and lipid membranes: the similarity of phenomenologies'Biochem. Biophys. Acta1987902p. 360-373
44. GlaserR.W. LeikinS.L. ChernomordikL.V. PastushenkoV.F. SokirkoA.V.: 'Reversible electrical breakdown of lipid bilayers: formation and evolution of pores'Biochem. Biophys. Acta1988940p. 275-287
45. WeaverJ. ChizmadzhevY.: 'Theory of electroporation: a review'Bioelectrochem. Bioenerg.199641p. 135-160 http://dx.doi.org/10.1016/S0302-4598(96)05062-3
46. MelikovK.C. FrolovV.A. ShcherbakovA. SamsonovA.V. ChizmadzhevY.A. ChernomordikL.V.: 'Voltage-induced nonconductive pre-pores and metastable single pores in unmodified planar lipid bilayers'Biophys. J.200180p. 1829-18360006-3495
47. IgarashiY. EroshkinA. GramatikovaS. GramatikoffG. ZhangY. SmithJ.W. OstermanA.L. GodzikA.: 'Cut DB: a proteolytic event database'Nucliec Acids Res.200735p. D546-D549 PMID: 17142225
48. DuffyM.J. LynnD.J. LloydA.T. O'SheaC.M.: 'The ADAMs family of proteins: from basic studies to potential clinical applications'Thrombos. Haemosta.200389(4)p. 622-631
49. MhakaA. GadyA.M. LoK.-M. GilliesS.D. DenmeadeS.R.: 'Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA)'Cancer Biol. Ther.20043p. 551-558
50. KrutzfeldtlJ. RajewskyN. BraichR.: et al. 'Silencing of microRNAs in vivo with "antagomirs" ''Nature2005438p. 685-6890028-0836